Status:

UNKNOWN

Prospective Monitoring of Angiotensin Receptor Neprilysin Inhibitor in Older Adults With Heart Failure and Frailty

Lead Sponsor:

Brigham and Women's Hospital

Conditions:

Heart Failure, Systolic

Frailty

Eligibility:

All Genders

65+ years

Brief Summary

The objective of this study is to establish a near-real-time prospective monitoring program in Medicare, Optum and MarketScan Research data to evaluate the benefit of new cardiovascular disease (CVD) ...

Detailed Description

Data sources of use for this study are: Medicare Database, Optum Database, and MarketScan Research Database. All data from years 2014-2020 will be included in the study. This study follows a sequenti...

Eligibility Criteria

Inclusion

  • Continuous enrollment for medical and drug insurance (e.g., Medicare Part A, B, and D) in \[-365, 0\] days
  • Diagnosis of Heart Failure either two outpatient diagnosis or one inpatient diagnosis in \[-365, 0\] days
  • Reduced Ejection Fraction \< 45% identified using a validated claims-based algorithm in \[-365, 0\] days
  • Day 0 is the initiation date of the study drug.

Exclusion

  • No prior use of Angiotensin receptor neprilysin inhibitor or angiotensin II receptor blocker in \[-365, -1\] days
  • No recent HF hospitalization, defined as HF diagnosis (defined in attached protocol) in the primary position in the inpatient dataset in \[-60, 0\] days
  • No recent nursing facility stay (defined in attached protocol) for \[-60, 0\] days
  • Age \< 65 years
  • Exposure to both drugs on day 0
  • Contraindication to either drug (exclusion assessment window: \[-60, 0\] days, unless specified otherwise; algorithms specified in attached protocol)
  • Note: If a patient meets the above-mentioned eligibility criteria more than once, only the first record will be included.

Key Trial Info

Start Date :

January 14 2021

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2022

Estimated Enrollment :

40000 Patients enrolled

Trial Details

Trial ID

NCT04743063

Start Date

January 14 2021

End Date

December 31 2022

Last Update

February 15 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Brigham And Women's Hospital

Boston, Massachusetts, United States, 02120